American Health Intel Rules. Money. Medicine. Decoded daily.
Subscribe
← All editions
Following a story · 2 updates

DEA telehealth rule at White House review

Nov 20, 2026 – Nov 21, 2026

  1. Nov 20, 2026 The Regulator Rule

    Telehealth prescribing flexibilities end Dec 31

    DEA and HHS extended telemedicine prescribing flexibilities for Schedule II to V drugs through December 31, 2026, while the permanent special registration final rule is projected for November 2026 and DEA reviews more than 6,400 comments.

    Read this issue →
  2. Nov 21, 2026 The Regulator Rule Latest

    DEA telehealth rule at White House review

    The permanent DEA Special Registrations for Telemedicine final rule is reportedly under Office of Information and Regulatory Affairs review, with current controlled-substance telemedicine flexibilities running through December 31, 2026.

    Read this issue →